Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.